VANCOUVER -  A joint project of the University of British Columbia and the BC Cancer Agency (BCCA) that links gene studies, biotechnology and cancer research has received $9.35 million from the Canadian Foundation for Innovation (CFI) for construction of a new biotechnology research building at UBC. 

The joint venture, called the Centre for Integrated Genomics (CIG), will provide a platform for the development and application of genomic science in many areas including forestry and plant studies and cancer genomics. Genome science or genomics identifies and decodes all the genes of a living organism.

The proposed integration of genomics with basic cancer research and clinical research has the potential for a major impact in cancer research, according to the CFI Genomics Review Panel which described CIG as an exciting and innovative concept.

Components of the CIG are the Genome Sequence Centre directed by Nobel laureate Michael Smith, the BC Cancer Research Centre led by Victor Ling and the UBC Biotechnology Laboratory directed by Douglas Kilburn.

The centre is unique in North America in that it will combine state-of-the-art gene research technology with the clinical practice of a comprehensive-service cancer organization.

BCCA and UBC will make further joint application to CFI in January 2000 to fund the remaining components of the research centre, focusing on building space and equipment needs.

The CFI is a $1-billion federal government fund designed to help universities, colleges and hospitals upgrade their research infrastructure.

The BC Cancer Agency provides a comprehensive cancer control program for the people of British Columbia by working with community partners to deliver a range of oncology services, including prevention, early detection, diagnosis and treatment, research, education, supportive care, rehabilitation and palliative care. The BC Cancer Research Centre conducts research into the causes and cures for cancer. The BC Cancer Foundation has a mandate to raise funds to support the work of the Agency and Research Centre, for a world without fear of cancer.

For more information, please call Francine Gaudet, APR Director
Communications and Public Relations BC Cancer Agency:
Ph: 604.877.6107
Fax: 604.877.6146